NVIDIA and Eli Lilly are investing up to $1 billion over five years in a San Francisco Bay Area AI co-innovation lab that pairs robotic wet labs with NVIDIA's BioNeMo and Vera Rubin computing platforms to run round-the-clock drug experiments.
Medtronic announced a roughly $700 million partnership with Cornerstone Robotics on September 1, 2026, taking distribution rights to its Sentire surgical system in select markets even as Medtronic's own Hugo robot expands to 35-plus countries.
MIT and Harvard researchers published an AI system called xvr in Nature on September 16, 2026, that matches a live surgical X-ray to a patient's pre-op 3D scan with sub-millimeter precision, outperforming existing methods by an order of magnitude.
Mayo Clinic is licensing CareCast, its internal workforce demand-forecasting technology, to staffing platform Trusted Health, which plans to commercialize the tool to other health systems battling chronic nurse shortages.
MyFitnessPal's 2026 Summer Release adds AI Coach, a feature that mines two decades of a user's own food-logging history to answer real-time questions like what to order at dinner or how to hit a protein target, alongside new GLP-1 tracking tools.
Novo Nordisk has partnered with Anthropic to deploy the AI company's new Claude Science model across its drug research and development workflows, aiming to become what its CEO calls 'the world's most AI-driven healthcare company.'
Data presented at the World Conference on Lung Cancer in Seoul show AI software from Softek scanning for incidental lung nodules caught more cancer cases than a standard low-dose CT screening program alone.
OSF HealthCare is extending RapidAI's automated stroke-imaging software to all of its hospitals, cutting the time it takes to spot brain-blocking clots and get patients into treatment.
Whoop is adding on-demand virtual clinician access, EHR syncing and new AI coaching tools like 'My Memory,' pushing the wearable maker further from fitness tracker toward full health platform.
Carna Health and Level Up have signed an MOU to bring AI-driven predictive analytics for cardio-kidney-metabolic syndrome to Kazakhstan, part of a wider push by health AI firms into international markets.